Search

Displaying results 6511 - 6520 of 10000 in total
  1. Drug

    NLX-P101

    go.drugbank.com/drugs/DB05924
    Experimental

    which is overactive in patients with Parkinson’s disease. … NLX-P101 is being evaluated as a therapeutic drug when injected into this deep brain structure that is known to function abnormally in Parkinson’s patients.

  2. Drug

    Tandamine

    go.drugbank.com/drugs/DB09192
    Experimental

    Tandamine was researched in 1970s as an antidepressant but was never commercialized. Tandamine is an analog of pirandamine and it acts as a selective serotonin reuptake inhibitor (SSRI).

  3. Drug

    Indisulam

    go.drugbank.com/drugs/DB06370
    Investigational

  4. Drug

    Apatorsen

    go.drugbank.com/drugs/DB06094
    Investigational

    Apatorsen is a second generation antisense drug which in preclinical experiments, inhibits production of Heat Shock Protein 27 (Hsp27) a cell survival protein found at elevated levels in many human cancers

  5. Drug

    Tangerine peel

    go.drugbank.com/drugs/DB14316
    Investigational

    Tangerine peel is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  6. Drug

    Coconut oil

    go.drugbank.com/drugs/DB14322
    Investigational

    Coconut oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  7. Drug

    Sunflower oil

    go.drugbank.com/drugs/DB14329
    Investigational

    Sunflower oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  8. Drug

    Chondrus crispus

    go.drugbank.com/drugs/DB14367
    Investigational

    Chondrus crispus is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  9. Drug

    Agrostis gigantea top

    go.drugbank.com/drugs/DB14757
    ApprovedWithdrawn

    Agrostis gigantea top is mainly used in allergenic testing.

  10. Drug

    HMI-103

    go.drugbank.com/drugs/DB17684
    Investigational

    HMI-102 is an investigational gene therapy designed to encode the phenylalanine-4-hydroxylase (PAH) gene, mutated in people with phenylketonuria.